AFL approves use of Regeneus's HiQCell

The AFL has added Regeneus (ASX:RGS) HiQCell to a list of approved treatments for injuries including impact-related osteoarthritis and tendonitis.

[+]

> Posted in Biotechnology on 28 August, 2014

Vaxxas recognised by WEF for vaccine tech

Vaxxas has been selected as a 2015 Technology Pioneer by the World Economic Forum for its patch-based vaccine delivery technology.

[+]

> Posted in Biotechnology on 27 August, 2014

Imugene names Charles Walker as new CEO

Former Alchemia (ASX:ACL) chief Charles Walker has taken the role of Imugene (ASX:IMU) CEO, to help lead the company's efforts to commercialise HER-Vaxx in gastric... [+]

> Posted in Health & medical on 26 August, 2014

Regeneus, Cryosite sign stem cell alliance

Regeneus (ASX:RGS) and Cryosite (ASX:CTE) have agreed to share technology and expertise in the area of stem cell products for human applications.

[+]

> Posted in Life sciences on 22 August, 2014

Sirtex profit grows 30% in FY14

Sirtex Medical (ASX:SRX) has posted a 30.6% increase in profit for FY14, as dose sales of its SIR-Spheres liver cancer treatment reached a record high. [+]

> Posted in Health & medical on 20 August, 2014

Latest News

Phylogica awarded three new peptide patents

Phylogica (ASX:PYC) has added a Japanese patent and two more from the US to its intellectual... [+]

> Posted in Biotechnology

AusBiotech welcomes Greens' push for quarterly payments on R&D Tax Incentive

AusBiotech fully supports the Australian Greens' moving of an amendment in the Senate to put... [+]

> Posted in Biotechnology

Mesoblast posts wider loss, details product roadmap

Mesoblast (ASX:MSB) has announced its financial results for FY14 and laid out a five-pronged... [+]

> Posted in Biotechnology

A new angle for preventing type 1 diabetes

Researchers have identified the specific portion of insulin that the immune system targets in... [+]

> Posted in Life sciences

ResMed scores initial win in ITC case against BMC

A US ITC judge has found in favour of ResMed (ASX:RMD) in the company's patent infringement... [+]

> Posted in Biotechnology

Click here for your FREE subscription

Australian Life Scientist: The Magazine

The magazine for research professionals in the life science and biotech sector across Australia. Click for your FREE subscription